ARK Investment Management LLC raised its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 32.5% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 212,959 shares of the medical instruments supplier’s stock after acquiring an additional 52,186 shares during the quarter. ARK Investment Management LLC’s holdings in DENTSPLY SIRONA were worth $3,382,000 at the end of the most recent quarter.
Other institutional investors also recently made changes to their positions in the company. Envestnet Asset Management Inc. raised its holdings in shares of DENTSPLY SIRONA by 9.0% in the first quarter. Envestnet Asset Management Inc. now owns 494,737 shares of the medical instruments supplier’s stock worth $7,391,000 after acquiring an additional 40,936 shares during the last quarter. Brown Advisory Inc. acquired a new position in shares of DENTSPLY SIRONA in the first quarter worth $679,000. Dynamic Technology Lab Private Ltd acquired a new position in shares of DENTSPLY SIRONA in the first quarter worth $366,000. Krilogy Financial LLC acquired a new position in shares of DENTSPLY SIRONA in the second quarter worth $336,000. Finally, BFI Infinity Ltd. purchased a new stake in shares of DENTSPLY SIRONA in the second quarter valued at $335,000. 95.70% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on XRAY shares. Wells Fargo & Company lowered their price objective on DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating for the company in a research report on Friday, August 8th. Barrington Research lowered their price target on DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating for the company in a research report on Friday, August 8th. Weiss Ratings reissued a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research report on Wednesday, October 8th. UBS Group lowered their price target on DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating for the company in a research report on Friday, August 8th. Finally, Stifel Nicolaus lowered their price target on DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a research report on Friday, August 8th. Two equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $18.00.
DENTSPLY SIRONA Trading Up 0.5%
Shares of NASDAQ XRAY opened at $13.03 on Thursday. The stock’s 50 day moving average price is $13.37 and its two-hundred day moving average price is $14.50. DENTSPLY SIRONA Inc. has a 52-week low of $11.69 and a 52-week high of $24.86. The stock has a market capitalization of $2.60 billion, a P/E ratio of -2.75, a PEG ratio of 0.81 and a beta of 0.96. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm had revenue of $936.00 million for the quarter, compared to analysts’ expectations of $929.67 million. During the same quarter in the prior year, the firm posted $0.49 earnings per share. DENTSPLY SIRONA’s revenue for the quarter was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.
DENTSPLY SIRONA Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, October 10th. Shareholders of record on Friday, September 26th were paid a dividend of $0.16 per share. The ex-dividend date was Friday, September 26th. This represents a $0.64 annualized dividend and a yield of 4.9%. DENTSPLY SIRONA’s dividend payout ratio is presently -13.50%.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Recommended Stories
- Five stocks we like better than DENTSPLY SIRONA
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Quanta Services: The Backbone of the AI Data Center Push
- How to start investing in penny stocks
- Archer’s Recent String of Victories Signals a New Phase of Growth
- What is the Shanghai Stock Exchange Composite Index?
- 3 Key Stocks Boosting Buybacks Amid Improving Fundamentals
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.